RPC
Rossmore Private Capital Portfolio holdings
AUM
$857M
1-Year Return
14.52%
This Quarter Return
+1.43%
1 Year Return
+14.52%
3 Year Return
+61.84%
5 Year Return
+132.85%
10 Year Return
–
AUM
$283M
AUM Growth
+$11.5M
(+4.2%)
Cap. Flow
+$9.02M
Cap. Flow
% of AUM
3.19%
Top 10 Holdings %
Top 10 Hldgs %
51.53%
Holding
133
New
5
Increased
33
Reduced
27
Closed
3
Top Buys
| 1 |
Microsoft
MSFT
|
$1.5M |
| 2 |
Stryker
SYK
|
$715K |
| 3 |
JPMorgan Chase
JPM
|
$642K |
| 4 |
Union Pacific
UNP
|
$507K |
| 5 |
Exxon Mobil
XOM
|
$495K |
Top Sells
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
$302K |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
$255K |
| 3 |
DuPont de Nemours
DD
|
$225K |
| 4 |
Intel
INTC
|
$224K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
$206K |
Sector Composition
| 1 | Energy | 28.86% |
| 2 | Financials | 11.02% |
| 3 | Technology | 8.68% |
| 4 | Healthcare | 7.08% |
| 5 | Consumer Staples | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Bio-Techne
TECH
$8.46B
| $208K | 0.07% |
+4,000
| New | +$208K |
|
127
GE Aerospace
GE
$296B
| $185K | 0.07% |
3,539
-103
| -3% | -$5.38K |
|
128
Oramed Pharmaceuticals
ORMP
$91.4M
| $54K | 0.02% |
15,061
| – | – |
|
129
Ocugen
OCGN
$322M
| $46K | 0.02% |
4,033
| – | – |
|
130
Globalstar
GSAT
$3.96B
| $18K | 0.01% |
2,460
| – | – |
|
|
131
iShares MSCI Emerging Markets ETF
EEM
$19.2B
| – | – |
-5,931
| Closed | -$255K |
|
|
132
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.6B
| – | – |
-5,718
| Closed | -$302K |
|
|
133
Intel
INTC
$107B
| – | – |
-4,174
| Closed | -$224K |
|